Sunflower® Therapeutics https://validator.w3.org/feed/docs/rss2.html INTERPHEX Fermenting for Pharma Kivi Bio Upstream & PUPSIT BioMaP-Consortium Join Us Women in Science: ‘Stay curious, be persistent, and embrace the power of mentorship’, says Kerry Love of Sunflower® Therapeutics Chemically Defined Media for Yeast | Sunflower® Application Note US DOD Awards $10.5M Contract To Sunflower® Therapeutics Roivant Social Ventures Initiates Partnering Activities with Investment in Sunflower® Lab to Launch Podcast: The future of protein manufacturing with Kerry Love, co-founder of Sunflower® Therapeutics Space-Time Yield | Sunflower® Application Note Sunflower® Therapeutics’ Daisy Petal® Named “Lifescience Manufacturing Solution of the Year” by BioTech Breakthrough Perfusion fermentation in the Daisy Petal® bioreactor | Sunflower® Application Note Video 3: Introduction to the Sunflower® Software Suite Improving Production of Recombinant Proteins through Yeast Strain Engineering | Sunflower® Application Note How Simplified Biomanufacturing Empowers Medical Innovators? Ft. Dr. Kerry Love, Co-Founder and CEO, Sunflower® Therapeutics Perfusion fermentation in the Daisy Petal® bioreactor sustains ultra-high biomass | Sunflower® Application Note Daisy Petal® simplifies fermentation optimization | Sunflower® Application Note A modular in-vessel cell retention device enables perfusion fermentation across diverse bioprocesses | Sunflower® Application Note Services Exceptionally Accessible Bioprocessing Software About Us Daisy Petal® Perfusion Bioreactor System Video 4: Creating a Recipe in Nursery™ Conflicts of Interest Policy Sunflower® Therapeutics Website Terms Of Use Policies Sunflower® Therapeutics Receives NIH SBIR Funding to Develop an Automated, Continuous Cell Disruption Platform for VLP-Based Vaccine Manufacturing Sunflower® Therapeutics Receives First Milestone Payment Through Collaboration with SK bioscience on Cost-Effective HPV Vaccine Empowering Europe’s protein bioeconomy with smarter, faster, and more adaptable continuous production methods Sunflower® Therapeutics Completes Major Installation of Daisy Petal® Systems at the Serum Institute of India, the World’s Largest Vaccine Manufacturer Sunflower® Therapeutics Privacy Policy Sunflower® Therapeutics Announces Exclusive Distribution Agreement with Alflow Scandinavia A/S Video 1: Introduction to the Daisy Petal Perfusion Bioreactor System Video 2: Installing the Single Use Assembly Our Team Sunflower Therapeutics Expands distribution into Japan with MATSUBO Corporation Characterization of a Potential Therapeutic Anti-Canine PD-1 Single Domain Antibody Produced in Yeast Perfusion fermentation sets a path to democratize biomanufacturing Adaptation of aglycosylated monoclonal antibodies for improved production in Komagataella phaffii Minimal purification method enables developability assessment of recombinant proteins Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffii Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice Equitable drug access: small-scale manufacturing units can help Resources News The Medicine Maker: Manufacturing a Fairer Future Genetic Engineering & Biotechnology News: Enhancing Biomanufacturing with Space-Time Yield Daisy Petal® Specification Sheet Home